Lilly Announces Agreement To Acquire ARMO BioSciences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Baird Downgrades ARMO BioSciences, Inc. (ARMO) to Neutral Following Acquisition
May 10, 2018 12:27 PM EDTBaird downgraded ARMO BioSciences, Inc. (NASDAQ: ARMO) from Outperform to Neutral with a price target of $50.00 (from $67.00).
For an analyst ratings summary and ratings history on ARMO BioSciences, Inc. click here. For more ratings news on ARMO BioSciences, Inc. click here.
Shares of ARMO BioSciences, Inc. closed at $29.82 yesterday.
... MoreBMO Capital Downgrades ARMO BioSciences, Inc. (ARMO) to Market Perform Following Takeover
May 10, 2018 11:03 AM EDTBMO Capital downgraded ARMO BioSciences, Inc. (NASDAQ: ARMO) from Outperform to Market Perform with a price target of $50.00.
For an analyst ratings summary and ratings history on ARMO BioSciences, Inc. click here. For more ratings news on ARMO BioSciences, Inc. click here.
Shares of ARMO BioSciences, Inc. closed at $29.82 yesterday.
... More